Otitis media: recent advances in otitis media vaccine development and model systems

A Zahid, JC Wilson, ID Grice, IR Peak - Frontiers in Microbiology, 2024 - frontiersin.org
Otitis media is an inflammatory disorder of the middle ear caused by airways-associated
bacterial or viral infections. It is one of the most common childhood infections as globally …

Vaccine targets against Moraxella catarrhalis

D Ren, ME Pichichero - Expert opinion on therapeutic targets, 2016 - Taylor & Francis
Introduction: Moraxella catarrhalis is a prominent pathogen that causes acute otitis media in
children and lower respiratory tract infections in adults, resulting in a significant …

Moraxella Catarrhalis: From Interactions with the Host Immune System to Vaccine Development

YC Su, B Singh, K Riesbeck - Future microbiology, 2012 - Taylor & Francis
Moraxella catarrhalis is a human-restricted commensal that over the last two decades has
developed into an emerging respiratory tract pathogen. The bacterial species is equipped …

Panel 6: vaccines

MM Pettigrew, MR Alderson… - … –Head and Neck …, 2017 - journals.sagepub.com
Objective To review the literature on progress regarding (1) effectiveness of vaccines for
prevention of otitis media (OM) and (2) development of vaccine antigens for OM bacterial …

Potential impact of a Moraxella catarrhalis vaccine in COPD

AC Perez, TF Murphy - Vaccine, 2019 - Elsevier
Moraxella catarrhalis is the second most common cause of exacerbations in adults with
COPD, resulting in enormous morbidity and mortality in this clinical setting. Vaccine …

[HTML][HTML] Formation and immunological evaluation of Moraxella catarrhalis glycoconjugates based on synthetic oligosaccharides

T Anderson, H Jiang, AN Cheallaigh, D Bengtsson… - Carbohydrate …, 2024 - Elsevier
Published work has shown that glycoconjugate vaccines, based on truncated detoxified
lipopolysaccharides from Moraxella catarrhalis attached through their reducing end to a …

Defensive and offensive cross-reactive antibodies elicited by pathogens: The good, the bad and the ugly

D Augustyniak, G Majkowska-Skrobek… - Current medicinal …, 2017 - ingentaconnect.com
Understanding how immunity to pathogens develops is crucial for progress in the quest for
effective vaccines. Intraspecies and interspecies cross-reacting antibodies are produced in …

Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1, 6 …

E Altman, V Chandan, BA Harrison, R Veloso-Pita, J Li… - Vaccine, 2012 - Elsevier
To investigate the vaccine potential of H. pylori lipopolysaccharide (LPS), truncated LPS of
H. pylori strain 26695 HP0826:: Kan lacking O-chain polysaccharide and comprising an …

Panel 6: vaccines

SI Pelton, MM Pettigrew… - … —Head and Neck …, 2013 - journals.sagepub.com
Objective To update progress on the effectiveness of vaccine for prevention of acute otitis
media (AOM) and identification of promising candidate antigens against Streptococcus …

An Unusual Carbohydrate Conformation is Evident in Moraxella catarrhalis Oligosaccharides

M Frank, PM Collins, IR Peak, ID Grice, JC Wilson - Molecules, 2015 - mdpi.com
Oligosaccharide structures derived from the lipooligosaccharide of M. catarrhalis show that
the highly branched glucose-rich inner core of the oligosaccharide has an altered …